Acknowledgements:
• The Australian Medical Research Future Fund and Sydney Health Partners • The Australian National Health and Medical Research Council
• The Cameron family for their generous support of clinical research data collection at Melanoma Institute Australia
• Colleagues at Melanoma Institute Australia and the Royal Prince Alfred, Westmead and Royal North Shore Hospitals, Sydney
• Melanoma Institute Australia’s generous donors and partners • Cancer Institute New South Wales • The Medical Foundation of The University of Sydney
• Colleagues from the University of Texas MD Anderson Cancer Center • Melanoma patients and the public who allowed their data to be used to develop and validate these melanoma risk tools
• Researchers and participants from the Australian Melanoma Family Study and GEM study
• The University of Sydney • The Sydney Local Health District • New South Wales Health Pathology